Health and Healthcare

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

1191 Articles

Chris Lange | Oct 4, 2018 at 11:40 AM EDT

Why Arrowhead Pharma’s New Agreement Is a Big Deal

Arrowhead Pharmaceuticals shares stumbled on Thursday after it announced a license and collaboration agreement with Janssen Pharmaceutica, a subsidiary of…

Paul Ausick | Sep 25, 2018 at 4:01 PM EDT

Intel, UnitedHealth Sink the Dow Tuesday

Intel, UnitedHealth, Johnson & Johnson, and 3M Company led the Dow's Tuesday drop.

Paul Ausick | Sep 5, 2018 at 4:01 PM EDT

Visa, Microsoft Hold Back the Dow Wednesday

Trading in the Dow 30 stocks was essentially flat Wednesday with Visa and Microsoft the leading losers while Caterpillar and…

Paul Ausick | Aug 20, 2018 at 4:01 PM EDT

Nike, Johnson & Johnson Lift the Dow Monday

Nike, Johnson & Johnson, Merck, and Home Depot were Monday's leading gainers.

Jon C. Ogg | Aug 14, 2018 at 5:35 PM EDT

Major Changes Seen in Berkshire Hathaway and Warren Buffett Stock Holdings

The more recent observations about Buffett's portfolio changes coming into mid-2018 have been quite different than many of the historic and traditional…

Jon C. Ogg | Aug 6, 2018 at 10:30 AM EDT

The Next 10 US Companies That Might Catch Apple in the $1 Trillion Value Club

It may not happen overnight, and a solid market correction would almost certainly interfere, but there are many companies that…

Douglas A. McIntyre | Aug 3, 2018 at 6:20 AM EDT

After Apple, Attention Turns Back to Market Risks

The success of Apple has hidden a multitude of problems within the larger market. Can the market hold on to…

Paul Ausick | Jul 24, 2018 at 4:01 PM EDT

United Technologies, Chevron Juice the Dow Tuesday

United Technologies, Chevron, Exxon Mobil, and Johnson & Johnson posted the Dow's biggest daily gains Tuesday.

Jon C. Ogg | Jul 24, 2018 at 10:40 AM EDT

How the Top 10 US Companies Rank in the $1 Trillion Market Cap Race

The quest for a U.S. company to reach $1 trillion in market capitalization continues, with Apple last seen leading the…

Lee Jackson | Jul 20, 2018 at 8:00 AM EDT

Top Analyst Bullish on Big Pharmaceutical Stocks Before Q2 Earnings

Four pharmaceutical industry leaders are poised to report second-quarter results next week, and one key analyst sees the relatively good…

Paul Ausick | Jul 19, 2018 at 4:01 PM EDT

American Express, Travelers Sink the Dow Thursday

Travelers, American Express, Walgreens, and Johnson & Johnson led the Dow lower Thursday.

Chris Lange | Jul 17, 2018 at 4:10 PM EDT

Tuesday’s Biggest Winners and Losers in the S&P 500

Tuesday was a positive day for the broad U.S. markets, after having an inauspicious start to the day. Crude oil…

Paul Ausick | Jul 17, 2018 at 4:01 PM EDT

Johnson & Johnson, Microsoft Lift the Dow Tuesday

Johnson & Johnson, DowDuPont, United Technologies, and Microsoft put up Tuesday's best gains among the Dow 30 stocks.

Chris Lange | Jul 17, 2018 at 8:45 AM EDT

Are Johnson & Johnson Q2 Earnings Good Enough?

Johnson & Johnson reported better-than-expected second-quarter financial results before the markets opened on Tuesday.

Chris Lange | Jul 16, 2018 at 10:25 AM EDT

What to Expect When Johnson & Johnson Reports Tuesday Morning

Johnson & Johnson is set to report its second-quarter financial results before the markets open on Tuesday.

1 … 29 30 31 32 33 … 80

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Why Arrowhead Pharma’s New Agreement Is a Big Deal

Intel, UnitedHealth Sink the Dow Tuesday

Visa, Microsoft Hold Back the Dow Wednesday

Nike, Johnson & Johnson Lift the Dow Monday

Major Changes Seen in Berkshire Hathaway and Warren Buffett Stock Holdings

The Next 10 US Companies That Might Catch Apple in the $1 Trillion Value Club

After Apple, Attention Turns Back to Market Risks

United Technologies, Chevron Juice the Dow Tuesday

How the Top 10 US Companies Rank in the $1 Trillion Market Cap Race

Top Analyst Bullish on Big Pharmaceutical Stocks Before Q2 Earnings

American Express, Travelers Sink the Dow Thursday

Tuesday’s Biggest Winners and Losers in the S&P 500

Johnson & Johnson, Microsoft Lift the Dow Tuesday

Are Johnson & Johnson Q2 Earnings Good Enough?

What to Expect When Johnson & Johnson Reports Tuesday Morning

Expert Warns: California Taxes Harming “Big Wealth Driver in the State” as Billionaires Flee

Switching to Medicare Advantage Is Easy. Switching Back Can Be Impossible

Forget Monthly Dividends Because These Three Roundhill ETFs Pay Investors on Different Days of the Week

Switching to Medicare Advantage Is Easy. Switching Back Can Be Impossible

Get Sick Overseas and Original Medicare Pays Almost Nothing. One Add-On Covers 80%

Expert Warns: California Taxes Harming “Big Wealth Driver in the State” as Billionaires Flee

Switching to Medicare Advantage Is Easy. Switching Back Can Be Impossible

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Why Arrowhead Pharma’s New Agreement Is a Big Deal

Intel, UnitedHealth Sink the Dow Tuesday

Visa, Microsoft Hold Back the Dow Wednesday

Nike, Johnson & Johnson Lift the Dow Monday

Major Changes Seen in Berkshire Hathaway and Warren Buffett Stock Holdings

The Next 10 US Companies That Might Catch Apple in the $1 Trillion Value Club

After Apple, Attention Turns Back to Market Risks

United Technologies, Chevron Juice the Dow Tuesday

How the Top 10 US Companies Rank in the $1 Trillion Market Cap Race

Top Analyst Bullish on Big Pharmaceutical Stocks Before Q2 Earnings

American Express, Travelers Sink the Dow Thursday

Tuesday’s Biggest Winners and Losers in the S&P 500

Johnson & Johnson, Microsoft Lift the Dow Tuesday

Are Johnson & Johnson Q2 Earnings Good Enough?

What to Expect When Johnson & Johnson Reports Tuesday Morning

Expert Warns: California Taxes Harming “Big Wealth Driver in the State” as Billionaires Flee

Switching to Medicare Advantage Is Easy. Switching Back Can Be Impossible

Forget Monthly Dividends Because These Three Roundhill ETFs Pay Investors on Different Days of the Week

Featured Reads

Switching to Medicare Advantage Is Easy. Switching Back Can Be Impossible

Get Sick Overseas and Original Medicare Pays Almost Nothing. One Add-On Covers 80%